Table: Taiko Pharmaceutical -2015/16 parent results
May 13 (Reuters)-
Taiko Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7.64 8.52
(-10.4 pct) (-11.6 pct)
Operating 1.08 2.31
(-53.1 pct) (+3.5 pct)
Recurring 1.69 2.56
(-33.9 pct) (+8.0 pct)
Net 1.29 1.67
(-22.5 pct) (+8.7 pct)
EPS 100.49 yen 131.04 yen
EPS Diluted 98.32 yen 126.83 yen
Ann Div 15.00 yen 25.00 yen 15.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 15.00 yen 25.00 yen 15.00 yen
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T
((Tokyo Headline News Desk +813 6441 1812))